Isabelle Boquet

The Transmembrane Semaphorin Sema4D/CD100, an Inhibitor of Axonal Growth, Is Expressed on Oligodendrocytes and Upregulated after CNS Lesion

Caroline Moreau‐Fauvarque, Atsushi Kumanogoh, Emeline Camand et al. · Journal of Neuroscience · 2003 · 289 citations · Full text

Life Sciences, Neurobiology, Neuroscience +15

Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial

Carlotta Antoniotti, Daniele Rossini, Filippo Pietrantonio et al. · The Lancet Oncology · 2022 · 270 citations · Full text

Medicine, Oncology, Pharmacotherapy +10

Immunoscore immune checkpoint using spatial quantitative analysis of CD8 and PD-L1 markers is predictive of the efficacy of anti- PD1/PD-L1 immunotherapy in non-small cell lung cancer

François Ghiringhelli, Frédéric Bibeau, Laurent Greillier et al. · EBioMedicine · 2023 · 86 citations · Full text

Life Sciences, Oncology, Pathology +17

491P Neoadjuvant nivolumab in early stage colorectal cancer

Antonio Avallone, Alfonso De Stefano, Ugo Pace et al. · Annals of Oncology · 2020 · 33 citations

Medicine, Oncology, Gastrointestinal Oncology +11

Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies

Enric Domingo, Caroline Kelly, Jennifer Hay et al. · Journal of Clinical Oncology · 2024 · 27 citations · Full text

Medicine, Oncology, Pharmacology +16